4//SEC Filing
Attar Eyal C. 4
Accession 0001415889-24-030316
CIK 0001817229other
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 4:15 PM ET
Size
4.9 KB
Accession
0001415889-24-030316
Insider Transaction Report
Form 4
Attar Eyal C.
CHIEF MEDICAL OFFICER
Transactions
- Sale
Common Stock
2024-12-27$1.25/sh−10,334$12,918→ 81,439 total
Footnotes (1)
- [F1]The transaction was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024.
Documents
Issuer
Vor Biopharma Inc.
CIK 0001817229
Entity typeother
Related Parties
1- filerCIK 0001789076
Filing Metadata
- Form type
- 4
- Filed
- Dec 30, 7:00 PM ET
- Accepted
- Dec 31, 4:15 PM ET
- Size
- 4.9 KB